<DOC>
	<DOCNO>NCT01612507</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability , pharmacokinetics different dose regimen Ceftaroline</brief_summary>
	<brief_title>A Study Assess Safety , Tolerability Pharmacokinetics Ceftaroline Healthy Subjects</brief_title>
	<detailed_description>A Phase I , Single Centre , Randomised , Double-blind , Placebo-controlled Parallel Group Study Assess Safety , Tolerability , Pharmacokinetics Ceftaroline Different Intravenous Dose Regimens Ceftaroline Fosamil Healthy Subjects</detailed_description>
	<mesh_term>Cephalosporins</mesh_term>
	<criteria>Provision sign date , write informed consent prior study specific procedure include optional safety biomarker analysis Healthy male female subject age 18 55 year ( inclusive ) suitable vein cannulation repeat venipuncture Women childbearing potential must negative pregnancy test , nonlactating , use highly effective form birth control 1 month prior enrollment , study , 3 month completion studyrelated proceed Have body mass index ( BMI ) 18 30 kg/m2 weigh least 50 kg 100 kg Has receive another new chemical entity ( define compound approve marketing ) participate clinical study include drug treatment within 3 month first administration investigational drug History clinically significant disease disorder , opinion Investigator , may either put subject risk participation study , influence result subject 's ability participate study Any positive result screen serum hepatitis B surface antigen , hepatitis C antibody , human immunodeficiency virus ( HIV ) History presence gastrointestinal , hepatic , renal disease condition know interfere absorption , distribution , metabolism , excretion drug Any clinically significant abnormality physical examination , 12lead ECG , vital sign , judge Investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>healthy volunteer</keyword>
	<keyword>Parallel Group Study</keyword>
	<keyword>ceftaroline fosamil different dos</keyword>
	<keyword>safety</keyword>
	<keyword>Cmax</keyword>
	<keyword>tmax</keyword>
	<keyword>AUC</keyword>
</DOC>